Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer
- 20 July 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Familial Cancer
- Vol. 5 (4), 305-308
- https://doi.org/10.1007/s10689-006-7850-4
Abstract
Familial pancreatic cancer (FPC) is a rare tumour syndrome and its underlying major gene defect is still unknown. Recently, CHEK2 has been identified as multi-organ cancer susceptibility gene associated with a predisposition to breast, prostate and colon cancer. Since these cancers also are associated with some FPC families, we have analysed 35 index patients of German FPC families for CHEK2 mutations. The CHEK2 * 1100delC mutation was found in 1 (3%) of 35 FPC families. Given the low expected mutation rate of up to 1.4% for CHEK2 * 1100delC in the European population our data are suggestive for possible contribution of CHEK2 mutations to a small subset of FPC.This publication has 31 references indexed in Scilit:
- An unfavourable prognosis for pancreatic cancer indicates fields of opportunityGut, 2006
- RNASEL germline variants are associated with pancreatic cancerInternational Journal of Cancer, 2005
- CHEK2 Is a Multiorgan Cancer Susceptibility GeneAmerican Journal of Human Genetics, 2004
- Prevalence of familial pancreatic cancer in GermanyInternational Journal of Cancer, 2004
- The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer?Hereditary Cancer in Clinical Practice, 2004
- Mutations in CHEK2 Associated with Prostate Cancer RiskAmerican Journal of Human Genetics, 2003
- CDKN2A Germline Mutations in Familial Pancreatic CancerAnnals of Surgery, 2002
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerAmerican Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone familiesCancer, 2001